Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 8.59
+0.14 (1.66%)
Sep 2, 2026, 3:00 PM CST
Cabio Biotech (Wuhan) Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 187.44 | 278.23 | 153.15 | 239.68 | 494.33 | 664.47 |
Trading Asset Securities | 164.05 | - | 0.03 | 0.03 | 32.8 | 11.5 |
Cash & Short-Term Investments | 351.48 | 278.23 | 153.18 | 239.71 | 527.13 | 675.97 |
Cash Growth | 20.09% | 81.63% | -36.10% | -54.53% | -22.02% | -21.48% |
Accounts Receivable | 156.74 | 196.56 | 285.41 | 265.64 | 216.43 | 178.29 |
Other Receivables | 9.64 | 42.76 | 36.39 | 31.01 | 40.56 | 41.08 |
Receivables | 166.38 | 239.31 | 321.81 | 296.65 | 256.99 | 219.37 |
Inventory | 194.59 | 173.27 | 139.32 | 112.58 | 81.49 | 74.86 |
Other Current Assets | 24.77 | 30.9 | 42.36 | 59.84 | 41.76 | 24.66 |
Total Current Assets | 737.23 | 721.72 | 656.67 | 708.78 | 907.37 | 994.85 |
Property, Plant & Equipment | 877.79 | 891.77 | 767.92 | 643.28 | 485.96 | 241.93 |
Long-Term Investments | 152.33 | 186.8 | 191.84 | 175.37 | 150.22 | 117.31 |
Other Intangible Assets | 42.49 | 43.47 | 43.09 | 41.08 | 36.34 | 13.15 |
Long-Term Deferred Tax Assets | 14.33 | 11.8 | 9.36 | 11.13 | 11.49 | 5.98 |
Long-Term Deferred Charges | 0.13 | 0.42 | 1.86 | 3.67 | 2.45 | 0.38 |
Other Long-Term Assets | 12.56 | 3.69 | 16.07 | 28.18 | 17.52 | 74.89 |
Total Assets | 1,837 | 1,860 | 1,687 | 1,611 | 1,611 | 1,448 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 93.29 | 93.25 | 62.07 | 70.86 | 107.34 | 31.43 |
Accrued Expenses | 5.87 | 18.12 | 21.97 | 15.32 | 19.15 | 18.05 |
Short-Term Debt | 70.05 | 36.67 | 6.01 | 11.01 | 30.03 | - |
Current Portion of Long-Term Debt | 7.18 | 0.04 | - | - | - | - |
Current Portion of Leases | - | 0.05 | 0.64 | 1.09 | 1.35 | 0.84 |
Current Income Taxes Payable | 2.24 | 4.11 | 5.18 | 5.86 | 16.02 | 5.22 |
Current Unearned Revenue | 5.8 | 3.82 | 0.76 | 2.08 | 0.43 | 0.23 |
Other Current Liabilities | 6.9 | 6.59 | 5.17 | 6.2 | 6.12 | 4.18 |
Total Current Liabilities | 191.32 | 162.63 | 101.79 | 112.42 | 180.44 | 59.95 |
Long-Term Debt | 98.84 | 49.53 | 12.63 | - | - | - |
Long-Term Leases | - | - | 0.02 | 0.66 | 1.66 | 1.58 |
Long-Term Unearned Revenue | 8.99 | 3.99 | 2.73 | 4.2 | 3.66 | 4.92 |
Long-Term Deferred Tax Liabilities | 0.16 | 0.02 | 0.11 | 0.31 | 0.54 | 0.22 |
Total Liabilities | 299.31 | 216.16 | 117.27 | 117.6 | 186.31 | 66.68 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 168.31 | 168.31 | 168.31 | 168.31 | 120 | 120 |
Additional Paid-In Capital | 811.97 | 812.01 | 811.83 | 811.83 | 858.02 | 844.82 |
Retained Earnings | 596.99 | 697.57 | 587.5 | 496.95 | 441.64 | 416.9 |
Treasury Stock | -45.17 | -43.09 | -10.82 | - | - | - |
Comprehensive Income & Other | -0.72 | -0.73 | -0.74 | -0.74 | -0.73 | -0.69 |
Total Common Equity | 1,531 | 1,634 | 1,556 | 1,476 | 1,419 | 1,381 |
Minority Interest | 6.19 | 9.44 | 13.46 | 17.54 | 6.1 | 0.79 |
Shareholders' Equity | 1,538 | 1,644 | 1,570 | 1,494 | 1,425 | 1,382 |
Total Liabilities & Equity | 1,837 | 1,860 | 1,687 | 1,611 | 1,611 | 1,448 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 176.07 | 86.28 | 19.29 | 12.76 | 33.05 | 2.42 |
Net Cash (Debt) | 175.42 | 191.95 | 133.89 | 226.95 | 494.08 | 673.55 |
Net Cash Growth | -14.39% | 43.37% | -41.01% | -54.07% | -26.65% | -21.76% |
Net Cash Per Share | 1.05 | 1.15 | 0.80 | 1.34 | 2.92 | 4.00 |
Filing Date Shares Outstanding | 167.69 | 166.46 | 167.75 | 168.31 | 168 | 168 |
Total Common Shares Outstanding | 167.69 | 166.46 | 167.75 | 168.31 | 168 | 168 |
Working Capital | 545.91 | 559.08 | 554.88 | 596.35 | 726.92 | 934.9 |
Book Value Per Share | 9.13 | 9.82 | 9.28 | 8.77 | 8.45 | 8.22 |
Tangible Book Value | 1,489 | 1,591 | 1,513 | 1,435 | 1,383 | 1,368 |
Tangible Book Value Per Share | 8.88 | 9.56 | 9.02 | 8.53 | 8.23 | 8.14 |
Buildings | - | 560.67 | 241.94 | 241.02 | 191 | 94.66 |
Machinery | - | 742.61 | 636 | 594.21 | 529.66 | 312.24 |
Construction In Progress | - | 13.82 | 265.55 | 133.05 | 49.59 | 104.18 |